Nasdaq:US$13.80 (+0.58) | HKEX:HK$21.70 (+0.40) | AIM:£2.18 (+0.06)
Search Result
Previous Article   |   Next Article
Announcements & Press Releases, Oncology / Immunology | 5 Nov 2009

Successful Global Phase IIb Ulcerative Colitis Trial for HMPL-004: All Primary and Secondary Endpoints Achieved Hutchison MediPharma Proceeding with Development and Partnership Plans

1 items
a091105